AbCellera Biologics Inc vs American Homes 4 Rent Class A — how do they compare? AbCellera Biologics Inc trades at $9.24 (market cap $2.99B), while American Homes 4 Rent Class A trades at $33.92 (market cap $12.28B). The key difference: American Homes 4 Rent Class A is far larger — about 4.1× AbCellera Biologics Inc's market cap, and American Homes 4 Rent Class A pays a 3.87% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AMH | |
|---|---|---|
Market Cap | $2.99B | $12.28B |
Sector | Health | Real Estate |
52-Week High | $9.76 | $35.82 |
52-Week Low | $2.78 | $27.38 |
Enterprise Value | $2.58B | $17.35B |
Dividend Yield | — | 3.87% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Read more on AMH →